Skip to content
AusGrant
Federal Forecasted GRANTS-GOV-351251

Critical Path Public Private Partnerships Clinical Trials Optional

Food and Drug Administration (HHS) · Competitive grant · Science & Technology

At a glance

Critical Path Public Private Partnerships Clinical Trials Optional is a federal competitive grant from Food and Drug Administration for the science & technology sector. Funding is up to $20M. Eligible applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification). Critical Path Institute. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.

Amount
Up to $20M
Deadline
Rolling
Type
Competitive
Status
Forecasted

About this program

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act.  This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.  

Who can apply

Others (see text field entitled "Additional Information on Eligibility" for clarification). Critical Path Institute

How to apply

Apply through Grants.gov using funding opportunity number FOR-FD-24-012. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source